US NEUROLOGY – VOLUME 14 ISSUE 1 – SPRING 2018
Welcome to the spring edition of US Neurology!
This edition opens with a selection of expert interviews covering the key themes of last year’s annual Alzheimer’s Association International Conference (AAIC), as well as topical aspects of epilepsy including presentations at the American Epilepsy Society (AES) annual meeting, which took place in December.
Nutrition and lifestyle are underlying topics across several of the articles, touching on multiple sclerosis, stroke and cognitive disorders. Daniel Hanley, et al. discuss the need to intensify therapy for intracerebral hemorrhage, and our Editor-in-Chief, Said Beydoun, and Jeffrey Rosenfeld provide a timely review of the clinical development of edaravone, the first therapy to receive FDA approval for amyotrophic lateral sclerosis in 22 years.
We hope you enjoy this edition, which will be distributed at the upcoming AAN meeting in Los Angeles – stop by the European Academy of Neurology (EAN), Movement Disorder Society (MDS) or Multiple Sclerosis Foundation (MSF) stands to pick up your free copy.
We are now accepting submission to our Fall edition, and welcome you to submit you manuscript here.